NEW DRUGS FOR EMERGING ANTIMICROBIAL RESISTANCE: SUSCEPTIBILITY PERFORMANCE OF CEFTAZIDIME-AVIBACTAM AND CEFTOLOZANE-TAZOBACTAM IN GRAM-NEGATIVE STRAINS FROM HEMATOLOGICAL PATIENTS
Lido
949
Vezesque se leu este artigo
372
Total PDF
577
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 21 | 11 | 32 |
| 2025 5 | 48 | 10 | 58 |
| 2025 4 | 29 | 11 | 40 |
| 2025 3 | 50 | 12 | 62 |
| 2025 2 | 31 | 19 | 50 |
| 2025 1 | 26 | 14 | 40 |
| 2024 12 | 21 | 13 | 34 |
| 2024 11 | 24 | 24 | 48 |
| 2024 10 | 28 | 19 | 47 |
| 2024 9 | 39 | 21 | 60 |
| 2024 8 | 44 | 27 | 71 |
| 2024 7 | 30 | 24 | 54 |
| 2024 6 | 36 | 17 | 53 |
| 2024 5 | 42 | 21 | 63 |
| 2024 4 | 38 | 21 | 59 |
| 2024 3 | 21 | 24 | 45 |
| 2024 2 | 14 | 22 | 36 |
| 2024 1 | 10 | 7 | 17 |
| 2023 12 | 10 | 23 | 33 |
| 2023 11 | 10 | 24 | 34 |
| 2023 10 | 5 | 8 | 13 |
Mostrar tudo
